Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine for hyperlactatemia prevention during CPB (Norcal)
NCT04312971Completed
- Sponsor
- Imam Abdulrahman Bin Faisal University
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in hyperlactatemia and Vasoplegic Syndrome (VPS) comparing Placebo with Norepinephrine (2 arms). Primary endpoint: Changes in lactic acid level at 24 hours. Started May 2020; status: completed.
02
Drugs
norepinephrine
03
Conditions
hyperlactatemiaVasoplegic Syndrome (VPS)
Beyond the preview
Go deeper on NCT04312971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312971.